BaseLaunch’s Post

$75m Secured by Biopharma in Dublin! 🌟 Dublin and Oxford-based SynOx Therapeutics has secured a robust $75M in Series B funding, underscoring Ireland's position as a leader in MedTech innovation. This funding will boost the development of their novel treatment providing groundbreaking solutions that could transform patient care and quality of life. As SynOx advances into late-stage clinical trials, its expertise in rare diseases and precise execution exemplify the kind of innovative spirit that cements Ireland's status as a MedTech exemplar. With a strong foundation in digital transformation and a deep talent pool, Ireland continues to lead the way in biopharmaceutical advancements. We at Hanley Automation are thrilled by the advancing and continuous manufacturing processes for biopharmaceuticals. Here's to more breakthroughs that bring innovations and growth into Irish life sciences! 🚀🍀 #LifeScience #Innovation #HealthcareInvestment #Biopharma #hanleyautomation #lifesciences

Thoughts on this? >> Century Therapeutics buys Clade; Eliem announces $120M PIPE and a deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharmaceutical #pharma #healthcare

Will you be joining our 10th annual Partner Symposium in Basel, Switzerland on March 6-7? If you're already part of the Genedata community but haven't yet signed up, it's not too late! View the agenda and register today: https://buff.ly/42UrGeL With talks from Janssen, GSK, and AstraZeneca to Merck, Pfizer, Genmab and many more, hear how Genedata accelerates R&D processes, resulting in increased efficiency and throughput. #GenedataSymposium #digitaltransformation #innovation #bioinformatics #computationalbiology

Are you a start-up leader looking to accelerate your research? Is your development-stage biopharmaceutical company looking to add research capabilities to your pipeline? Is your venture firm seeking a fast way to validate innovative new ideas or incubate early therapeutics? Then come hear Eric Furfine PhD, CEO/CSO of Mosaic Biosciences, at PepTalk this week, describing how we carry out advanced discovery-stage research and are changing the way drug discovery is done. If you answered yes to the questions above, but aren’t attending PepTalk, check out our website (www.mosaicbio.com ) to learn more and to make a connection. #biotechnology #proteintherapeutics #antibodydiscovery #drugdiscovery #peptalk

Here is the highlights from one of the biggest gatherings of the biopharmaceutical industry, where innovators, thought leaders, and curious minds came together to shape the future of healthcare. From insightful sessions to engaging discussions, this year's conclave was a powerhouse of knowledge-sharing and collaboration. This year, we also hosted the Biopharma Leaders' Roundtable, where industry trailblazers discussed driving innovative pipelines for cost-effective biologics in India. Here’s to driving the future of Biopharma together Ruchi Kedia Rima Fodkar Archana Shantharam Sheron David Pratibha Gupta Sarfaraz Ali #BiopharmaConclave2024 #Biopharma #CPHIConferences #InformaMarkets

I’m excited to announce the launch of PitchBook’s Pharma Services coverage. Download the full report here: https://lnkd.in/gc6NeNTK Pharma services is undoubtedly the hottest segment of PE healthcare investing, driven by underlying growth in the biopharmaceutical industry, the demand for greater specialization to develop and manufacture specialty drugs, and opportunities to bring scale and tech enablement to fragmented markets like trial site management and commercialization. Our new report tracks deal trends across the industry. Clients can access the underlying, curated data via the PitchBook platform. Many thanks to Dan Shoenholz and Ashwin Singhania of EY-Parthenon and Sam Fertitta and Andrew R. Karlin of Edgemont Partners for contributing their insights to the report. Finally - for a deeper VC/tech angle on the life sciences tools & services industry, stay tuned for our Pharmatech coverage launch next week.

Thoughts on this? >> Biogen CEO Viehbacher undaunted by Lilly's impending Alzheimer's therapy, saying it will ‘expand’ market >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #healthcare #pharma

Thoughts on this? >> Century Therapeutics buys Clade; Eliem announces $120M PIPE and a deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #productmarketing #healthcare #pharma

Financial Times's U.S. Pharma and Biotech Summit will take place in New York on May 16. Panel sessions will dive into funding pharma and biotech innovation, AI, pharma workforces and more. More details in this article from Pharmaceutical Executive: #pharma | #biotech | #innovation | #healthcare

An insightful and memorable time at SLAS (Society for Laboratory Automation and Screening) in Boston last month. Read below for our key takeaways from the show! #SLAS2024 #LabAutomation